交易中 09-19 13:11:43 美东时间
+0.110
+6.04%
UBS analyst Eliana Merle maintains RAPT Therapeutics (NASDAQ:RAPT) with a Neutral and lowers the price target from $10 to $2.
09-09 22:23
RAPT Therapeutics Inc : UBS Cuts Target Price to $2 From $10
09-06 21:41
智能戒指概念日前受到投资者关注,多家公司在互动平台回复投资者相关问题。①天键股份:公司在健康医疗领域以自主品牌为主,智能戒指以“RAPTGO”为品牌,具有运动监...
09-02 15:28
天键股份(301383)在互动平台表示,公司在健康医疗领域以自主品牌为主,智能戒指以“RAPTGO”为品牌,具有运动监测等功能。目前线上有在京东平台销售,线下也...
09-02 15:22
华金证券表示,伴随着技术的发展,可穿戴设备的品类也在快速扩容。可穿戴设备持续演进,相关产业链有望迎来爆发式增长。 据媒体报道,近日,TechInsights发...
09-02 07:54
【今日导读】 中国引领全球折叠屏手机市场增长:荣耀Q2销量激增455% 消费电子钛合金新“潮”迭起,200亿美元市场放量加速 谷歌发布世界首个AI游戏...
09-01 16:29
成分股Humacyte也跌9.62%,Lyell Immunopharma跌12.41%,RAPT Therapeutics跌13.36%,ACELYRIN跌...
08-15 05:13
RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.72) by 1.39 percent. This is a 7.58 percent decrease over losses of $(0.66) per share from
08-08 20:27
RAPT Therapeutics Q2 Net Income USD -27.663 Million
08-08 20:00
RAPT Therapeutics Q2 Operating Expenses USD 29.33 Million
08-08 20:00